Literature DB >> 31560078

[Granulomatous rosacea in a lung transplant recipient : A possible therapy option in a unique group of patients].

Claudia Ansorge1, Kristin Technau-Hafsi.   

Abstract

Rosacea, a frequent chronic inflammatory disease of the adnexal structures, is associated with an increased number of demodex mites. In patients with immunosuppression, it can present in fulminant progressions like granulomatous rosacea. In this specific subgroup of patients, treatment is not only complicated by aggressive occurrences, but is also limited by possible drug interactions with immunosuppressive drugs. We present a case of a 66-year-old lung transplant recipient, who was successfully treated with oral metronidazole and ivermectin cream.

Entities:  

Keywords:  Demodex mites; Immunosuppression; Ivermectin; Metronidazole; Systemic therapy

Mesh:

Substances:

Year:  2020        PMID: 31560078     DOI: 10.1007/s00105-019-04479-0

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  10 in total

1.  [Metronidazole: alternative treatment for ocular and cutaneous rosacea in the pediatric population].

Authors:  S Léoni; N Mesplié; F Aitali; M Chamaillard; F Boralevi; C Marques da Costa; A Taïeb; C Léauté-Labrèze; J Colin; B Mortemousque
Journal:  J Fr Ophtalmol       Date:  2011-08-31       Impact factor: 0.818

Review 2.  State of the art: systemic rosacea management.

Authors:  M Schaller; H Schöfer; B Homey; U Gieler; P Lehmann; T A Luger; T Ruzicka; M Steinhoff
Journal:  J Dtsch Dermatol Ges       Date:  2016-12       Impact factor: 5.584

3.  Rosacea - S1 guideline.

Authors:  Markus Reinholz; Julia K Tietze; Katharina Kilian; Martin Schaller; Helmut Schöfer; Percy Lehmann; Manfred Zierhut; Winfried Klövekorn; Thomas Ruzicka; Jürgen Schauber
Journal:  J Dtsch Dermatol Ges       Date:  2013-05-06       Impact factor: 5.584

Review 4.  Integrative concepts of rosacea pathophysiology, clinical presentation and new therapeutics.

Authors:  Anna D Holmes; Martin Steinhoff
Journal:  Exp Dermatol       Date:  2016-10-09       Impact factor: 3.960

5.  Demodicosis in Renal Transplant Recipients.

Authors:  R J Chovatiya; O R Colegio
Journal:  Am J Transplant       Date:  2015-10-02       Impact factor: 8.086

Review 6.  Metronidazole treatment in rosacea.

Authors:  P G Nielsen
Journal:  Int J Dermatol       Date:  1988 Jan-Feb       Impact factor: 2.736

Review 7.  Association of Metronidazole with Cancer: A Potential Risk Factor or Inconsistent Deductions?

Authors:  Muhammad Adil; Waheed Iqbal; Fazal Adnan; Shabnam Wazir; Imran Khan; M Umar Khayam; Mohammad Amjad Kamal; Shafiq Ahmad; Jawad Ahmed; Ishaq N Khan
Journal:  Curr Drug Metab       Date:  2018       Impact factor: 3.731

Review 8.  Rosacea Management: Update on general measures and topical treatment options.

Authors:  M Schaller; H Schöfer; B Homey; M Hofmann; U Gieler; P Lehmann; T A Luger; T Ruzicka; M Steinhoff
Journal:  J Dtsch Dermatol Ges       Date:  2016-12       Impact factor: 5.584

9.  Superior Efficacy with Ivermectin 1% Cream Compared to Metronidazole 0.75% Cream Contributes to a Better Quality of Life in Patients with Severe Papulopustular Rosacea: A Subanalysis of the Randomized, Investigator-Blinded ATTRACT Study.

Authors:  Martin Schaller; Thomas Dirschka; Lajos Kemény; Philippe Briantais; Jean Jacovella
Journal:  Dermatol Ther (Heidelb)       Date:  2016-07-18

10.  Topical Treatment of Rosacea with Ivermectin Inhibits Gene Expression of Cathelicidin Innate Immune Mediators, LL-37 and KLK5, in Reconstructed and Ex Vivo Skin Models.

Authors:  Séverine Thibaut de Ménonville; Carine Rosignoli; Estelle Soares; Manon Roquet; Béatrice Bertino; Jean-Paul Chappuis; Claire Defoin-Platel/Chaussade; David Piwnica
Journal:  Dermatol Ther (Heidelb)       Date:  2017-02-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.